SAB Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CALIGAN PARTNERS LP | 08/14/2026 | 7.97 M | $31.07 M | 0.00% | 9.99% |
| VIVO CAPITAL, LLC | 08/14/2026 | 7.30 M | $28.47 M | -36.08% | 9.15% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 6.63 M | $25.85 M | 3.04% | 8.31% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2026 | 6.41 M | $24.98 M | 88.09% | 8.03% |
| RA CAPITAL MANAGEMENT, L.P. | 08/14/2026 | 4.40 M | $17.17 M | 0.00% | 5.52% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 3.76 M | $14.67 M | 0.00% | 4.72% |
| BLACKROCK, INC. | 08/07/2026 | 3.07 M | $11.96 M | 917.51% | 3.84% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 2.97 M | $11.59 M | 19.22% | 3.73% |
| COMMODORE CAPITAL LP | 08/14/2026 | 2.87 M | $11.19 M | -34.80% | 3.60% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.75 M | $10.72 M | -9.35% | 3.45% |
| SPRUCE STREET CAPITAL LP | 08/13/2026 | 2.20 M | $8.57 M | 0.00% | 2.76% |
| SESSA CAPITAL IM, L.P. | 08/14/2026 | 2.20 M | $8.57 M | 0.00% | 2.76% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 1.53 M | $5.95 M | 165.22% | 1.91% |
| BOOTHBAY FUND MANAGEMENT, LLC | 08/14/2026 | 1.48 M | $5.78 M | 0.00% | 1.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.28 M | $4.98 M | 322.86% | 1.60% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.18 M | $4.60 M | -58.61% | 1.48% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 1.17 M | $4.57 M | -14.75% | 1.47% |
| PROPEL BIO MANAGEMENT, LLC | 08/13/2026 | 1.08 M | $4.20 M | 6.30% | 1.35% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 900.00 K | $3.51 M | -14.29% | 1.13% |
| SEVEN FLEET CAPITAL MANAGEMENT LP | 08/17/2026 | 736.08 K | $2.87 M | 636.08% | 0.92% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 611.02 K | $2.38 M | -58.61% | 0.77% |
| STATE STREET CORP | 08/07/2026 | 530.83 K | $2.07 M | 615.11% | 0.67% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 438.52 K | $1.71 M | 100.00% | 0.55% |
| DV EQUITIES, LLC | 08/14/2026 | 400.00 K | $1.56 M | 100.00% | 0.50% |
| AWM INVESTMENT COMPANY, INC. | 08/14/2026 | 375.00 K | $1.46 M | -6.25% | 0.47% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 373.98 K | $1.46 M | 89.24% | 0.47% |
| UBS GROUP AG | 08/13/2026 | 365.88 K | $1.43 M | 684.76% | 0.46% |
| NORTHERN TRUST CORP | 08/13/2026 | 362.49 K | $1.41 M | 531.23% | 0.45% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 342.63 K | $1.34 M | -8.63% | 0.43% |
| HB WEALTH MANAGEMENT, LLC | 07/29/2026 | 307.50 K | $1.20 M | 0.00% | 0.39% |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | 08/13/2026 | 306.58 K | $1.20 M | 100.00% | 0.38% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 292.73 K | $1.14 M | 100.00% | 0.37% |
| JANE STREET GROUP, LLC | 08/14/2026 | 226.50 K | $883.35 K | 2,099.03% | 0.28% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 214.63 K | $837.07 K | 18.46% | 0.27% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 191.31 K | $746.09 K | 67.90% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 107.85 K | $420.60 K | 100.00% | 0.14% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 105.68 K | $412.16 K | 100.00% | 0.13% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 105.68 K | $412.16 K | 100.00% | 0.13% |
| SIMPLIFY ASSET MANAGEMENT INC. | 07/16/2026 | 104.85 K | $408.91 K | -44.00% | 0.13% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 84.69 K | $330.27 K | 126.10% | 0.11% |
| CITADEL ADVISORS LLC | 09/02/2026 | 81.00 K | $315.90 K | 88.81% | 0.10% |
| ALPS ADVISORS INC | 07/29/2026 | 77.60 K | $302.64 K | 100.00% | 0.10% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 73.27 K | $285.76 K | 46.54% | 0.09% |
| CITADEL ADVISORS LLC | 09/02/2026 | 62.80 K | $244.91 K | 100.00% | 0.08% |
| NUVEEN, LLC | 08/11/2026 | 58.40 K | $227.75 K | 100.00% | 0.07% |
| JANE STREET GROUP, LLC | 08/14/2026 | 53.60 K | $209.04 K | -25.66% | 0.07% |
| PATHSTONE HOLDINGS, LLC | 08/13/2026 | 50.65 K | $197.54 K | 0.00% | 0.06% |
| KESTRA ADVISORY SERVICES, LLC | 07/28/2026 | 49.81 K | $194.26 K | -19.32% | 0.06% |
| RHUMBLINE ADVISERS | 08/12/2026 | 45.16 K | $176.13 K | 100.00% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 44.08 K | $171.92 K | 100.00% | 0.06% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
SAB Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 116 institutional investors and hedge funds held shares of SAB Biotherapeutics Inc. The most heavily invested institutionals were:
Caligan Partners LP: 7.97 M
Vivo Capital, LLC: 7.3 M
PERCEPTIVE ADVISORS LLC: 6.63 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 6.41 M
RA CAPITAL MANAGEMENT, L.P.: 4.4 M
BALYASNY ASSET MANAGEMENT L.P.: 3.76 M
85.89% of SAB Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 71.42 M shares in the last 24 months. This purchase volume represents approximately $274.25 M in transactions.